Paul Hastings Represents Applied Biosystems in the Acquisition of Agencourt Personal Genomics for $120 million

July 19, 2006

Paul Hastings Represents Applied Biosystems in the Acquisition of Agencourt Personal Genomics for $120 million

Los Angeles, CA and New York, NY (July 19, 2006) - The Mergers & Acquisition Group of Paul, Hastings, Janofsky & Walker LLP (Paul Hastings), a leading international law firm, represented client Applied Biosystems, an Applera Corporation business in the acquisition of Agencourt Personal Genomics (APG), a privately-held developer of next-generation genetic analysis technologies, for approximately $120 million in cash. The transaction closed on July 10, 2006.

APG was incorporated in 2005 as a separate company owned by Agencourt Bioscience Corp. The parent company was acquired by Beckman Coulter Inc. later that year. Since then, Beckman Coulter has owned 49 percent of APG, with 51 percent held by APG management and other shareholders.

The Paul Hastings team, led by M&A partner Deyan Spiridonov, also included associates Teri O'Brien and Iver Larson.
About Applera Corporation and Applied Biosystems: Consisting of two operating groups, the Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services.

Paul Hastings Janofsky & Walker LLP, founded in 1951, is a leading international law firm with over 1,000 attorneys in 17 offices. The firm serves a diverse client base including many of the top financial institutions and Fortune 500 companies, supports clients in all of their legal needs and offers deep capabilities in Banking and Finance, Capital Markets, Corporate/M+A, Litigation and Dispute Resolution, Intellectual Property, Project Finance, Investment Management, Real Estate, Labor and Employment and Tax Advisory Services. For additional information, please visit our website at www.paulhastings.com.

# # #